The value of tumor-stroma ratio as predictor of pathologic response after neoadjuvant chemoradiotherapy in esophageal cancer

BACKGROUND AND PURPOSE: With currently available techniques, the prediction of pathologic complete response after neoadjuvant chemoradiotherapy is insufficient. The tumor-stroma ratio (TSR) has proven to be a predictor of survival for several types of cancer, including esophageal. The aim of this st...

Descripción completa

Detalles Bibliográficos
Autores principales: van Pelt, G.W., Krol, J.A., Lips, I.M., Peters, F.P., van Klaveren, D., Boonstra, J.J., de Steur, W.O., Tollenaar, R.A.E.M., Farina Sarasqueta, A., Mesker, W.E., Slingerland, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906651/
https://www.ncbi.nlm.nih.gov/pubmed/31886418
http://dx.doi.org/10.1016/j.ctro.2019.11.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906651/
https://www.ncbi.nlm.nih.gov/pubmed/31886418
http://dx.doi.org/10.1016/j.ctro.2019.11.003

Ejemplares similares